Clinical trial diversity data show mismatch between enrollment and disease prevalence, GSK says
A lack of diversity in clinical trials has persisted despite decades of initiatives to try to turn the tide. In a recent review of 17 years of clinical trials, drugmaker GSK found that there were some mismatches between the demographics of its US-based trials and how…#clinicaltrials #gsk #disease #ethnic #blackafrican #censuslevels #copd #asians #vaccinetrials #accountabilityoffice
Source: Reuters: Health - Category: Consumer Health News Source Type: news